Less Ads, More Data, More Tools Register for FREE

Pin to quick picksBk. Cyprus Hldg Regulatory News (BOCH)

Share Price Information for Bk. Cyprus Hldg (BOCH)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 368.00
Bid: 367.00
Ask: 372.00
Change: -8.00 (-2.13%)
Spread: 5.00 (1.362%)
Open: 382.00
High: 382.00
Low: 368.00
Prev. Close: 376.00
BOCH Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Completion of Project Helix 2 (Portfolios A and B)

28 Jun 2021 11:24

RNS Number : 3322D
Bank of Cyprus Holdings PLC
28 June 2021
 

Announcement

 

Completion of Project Helix 2 (Portfolios A and B) - Sale ofnon-performing loans

 

Nicosia, 28 June 2021

 

 

Bank of Cyprus Holdings Public Limited Company ("BOC Holdings" and, together with its subsidiaries, the "Group") is pleased to announce the completion of Project Helix 2 (Portfolios A and B).

 

Project Helix 2 (the "Transaction") refers to the sale of portfolios of loans with a total gross book value of €1,339 mn1 (of which €1,311 mn1 relate to non-performing exposures) ("Portfolios A and B"), secured over real estate collateral, to funds affiliated with Pacific Investment Management Company LLC ("PIMCO"), the agreements for which were announced on 3 August 2020 and on 18 January 2021.

 

The net consideration for the Transaction amounts to c.€560 mn, of which c.€165 mn have been received in cash by completion. The remaining amount is payable in four instalments up to December 2025 without any conditions attached. The net consideration reflects adjustments resulting from, inter alia, loan repayments received on the Portfolios since the reference date of 30 September 2019. The consideration can be increased through an earnout arrangement, depending on the performance of each of the Portfolios.

 

The completion of the Transaction increases the Group's CET1 ratio as at 31 March 2021 of 14.4% to 14.6% (pro forma). Overall, including the release of risk weighted assets, the impact of the Transaction on the Group's CET1 ratio since the agreements were signed in August 2020 for Portfolio A and January 2021 for Portfolio B is c.-50 basis points1. Post completion, the Transaction is expected to have an additional positive capital impact of c.65 basis points1 on the Group's CET1 ratio, upon the full payment of the deferred consideration and without taking into consideration any positive impact from the earnout, thus making the Transaction overall capital accretive.

 

The Transaction represents a further milestone in the delivery of one of the Group's strategic priorities of improving asset quality through the reduction of NPEs. Project Helix 2 (Portfolios A and B) reduces the NPE ratio by 9 percentage points1 from 25%1 to 16%1 (pro forma). Overall, since the peak in 2014, the stock of NPEs has been reduced by €13.3 bn1 or 89%1 and the NPE ratio by 47 percentage points1, from 63% to 16%1, on the same basis.

 

For further information, please contact Investor Relations at investors@bankofcyprus.com.

 

 

 

1 Based on the Group financial results for the quarter ended 31 March 2021

 

 

Group Profile

 

The Bank of Cyprus Group is the leading banking and financial services group in Cyprus, providing a wide range of financial products and services which include retail and commercial banking, finance, factoring, investment banking, brokerage, fund management, private banking, life and general insurance. The Bank of Cyprus Group operates through a total of 91 branches in Cyprus, of which 11 operate as cash offices. Bank of Cyprus also has representative offices in Russia, Ukraine and China. The Bank of Cyprus Group employs 3,557 staff worldwide. At 31 March 2021, the Group's Total Assets amounted to €23.0 bn and Total Equity was €2.1 bn. The Bank of Cyprus Group comprises Bank of Cyprus Holdings Public Limited Company, its subsidiary Bank of Cyprus Public Company Limited and its subsidiaries.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
AGRFPMMTMTTTBTB
Date   Source Headline
28th Aug 20207:00 amRNSGroup Financial Results for 1H2020
20th Aug 20206:18 pmRNSDate of Announcement of 1H2020 FR
17th Aug 20209:14 amRNSDate of announcement of 1H2020 FR
3rd Aug 20207:00 amRNSAgreement for sale of a portfolio of NPLs
21st Jul 20204:41 pmRNSSecond Price Monitoring Extn
21st Jul 20204:36 pmRNSPrice Monitoring Extension
29th Jun 20208:56 amRNSTR1 Form -Morgan Stanley
8th Jun 20205:35 pmRNSSpring EU-wide Transparency Exercise 2020
4th Jun 20208:13 amRNSTR-1 Notification - Caius
27th May 20202:23 pmRNSReplacement AGM Resolutions
26th May 20204:41 pmRNSSecond Price Monitoring Extn
26th May 20204:36 pmRNSPrice Monitoring Extension
26th May 20202:14 pmRNSResolutions of the Shareholders AGM
26th May 20202:03 pmRNSDirectorate Change
26th May 20207:04 amRNSDoc re. (1Q2020 Investor Presentation)
26th May 20207:00 amRNS1Q2020 Group Financial Results
14th May 202011:10 amRNSNotice of 1Q2020 Results
30th Apr 20203:25 pmRNSPillar 3 Disclosures for 2019
29th Apr 20209:44 amRNSBOC Annual Financial Report 2019
29th Apr 20209:39 amRNSBOCH Annual Financial Report 2019
29th Apr 20207:02 amRNSDoc re. (FY2019 Investor Presentation)
29th Apr 20207:00 amRNSFY2019 Group Financial Results
24th Apr 20209:29 amRNSNotice of AGM
16th Apr 20209:19 amRNSNotice of Results
15th Apr 20207:47 amRNSTR-1 Standard Form for Morgan Stanley
15th Apr 20207:37 amRNSChanges in the Board Composition
9th Apr 202012:08 pmRNSSecond Price Monitoring Extn
9th Apr 202012:02 pmRNSPrice Monitoring Extension
8th Apr 202012:08 pmRNSSecond Price Monitoring Extn
8th Apr 202012:03 pmRNSPrice Monitoring Extension
6th Apr 20204:41 pmRNSSecond Price Monitoring Extn
6th Apr 20204:36 pmRNSPrice Monitoring Extension
3rd Apr 202012:07 pmRNSSecond Price Monitoring Extn
3rd Apr 202012:02 pmRNSPrice Monitoring Extension
2nd Apr 20204:41 pmRNSSecond Price Monitoring Extn
2nd Apr 20204:36 pmRNSPrice Monitoring Extension
30th Mar 20204:41 pmRNSSecond Price Monitoring Extn
30th Mar 20204:36 pmRNSPrice Monitoring Extension
27th Mar 20204:40 pmRNSSecond Price Monitoring Extn
27th Mar 20204:36 pmRNSPrice Monitoring Extension
27th Mar 202012:07 pmRNSSecond Price Monitoring Extn
27th Mar 202012:02 pmRNSPrice Monitoring Extension
20th Mar 20204:44 pmRNSSecond Price Monitoring Extn
20th Mar 20204:37 pmRNSPrice Monitoring Extension
20th Mar 202010:25 amRNSAnnouncement
19th Mar 202012:07 pmRNSSecond Price Monitoring Extn
19th Mar 202012:03 pmRNSPrice Monitoring Extension
16th Mar 20206:05 pmRNSTrading Update
16th Mar 20205:55 pmRNSUpdate on Coronavirus & NPE Sale
16th Mar 20204:39 pmRNSPrice Monitoring Extension

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.